Nanomedicine is an emerging field that exploits nanotechnology for the development of
novel therapeutic and diagnostic modalities. Researches are been focussed in nanoimaging …

Arsenic trioxide (ATO) is an approved therapy for the treatment of acute promyelocytic
leukemia, but the extension of arsenic-based therapies to other types of malignancies …

A lateral phototransistor structure based on mechanically exfoliated multilayer black arsenic
(b-As) is produced to test its in-plane anisotropy of photoelectrical properties. First, the …

Diagnosis of benign and malignant small nodules of the lung remains an unmet clinical
problem which is leading to serious false positive diagnosis and overtreatment. Here, we …

Due to multidrug resistance and the high risk of recurrence, effective and less toxic
alternative pancreatic cancer treatments are urgently needed. Pancreatic cancer cells are …

Liver cancer (LC), one of the most common malignant primary tumors, presents a poor
prognosis, high morbidity rate, and poor clinical outcomes. Despite conventional treatments …

Antibiotics, as widely used antibacterial drug, exist in various environmental media.
Antibiotic residues can affect biological metabolism and lead to bacterial resistance and the …

In recent years, two-dimensional (2D) layer materials have shown great potential in the field
of cancer diagnosis and treatment due to their unique structural, electronic, and chemical …

Arsenic trioxide (As2O3) has achieved groundbreaking success in the treatment of acute
promyelocytic leukemia (APL). However, its toxic side effects seriously limit its therapeutic …

Arsenic trioxide (ATO) is highly effective for acute promyelocytic leukemia but has limited
potency in solid tumors. Mitigating the systemic toxicity of ATO while enhancing its efficacy in …